Page last updated: 2024-08-26

sr141716 and Diarrhea

sr141716 has been researched along with Diarrhea in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anthenelli, RM; Aubin, HJ; Cinciripini, PM; Dale, LC; Karam-Hage, M; Niaura, R; Robinson, JD1
Capasso, F; Capasso, R; Izzo, AA; Mascolo, N; Pinto, L1
Borrelli, F; Capasso, F; Capasso, R; Izzo, AA; Mascolo, N; Pinto, L1
Lichtman, AH; Loh, HH; Martin, BR; Sheikh, SM1

Trials

1 trial(s) available for sr141716 and Diarrhea

ArticleYear
Pooled analysis of three randomized, double-blind, placebo controlled trials with rimonabant for smoking cessation.
    Addiction biology, 2018, Volume: 23, Issue:1

    Topics: Adult; Anorexia; Anxiety; Cannabinoid Receptor Antagonists; Cigarette Smoking; Diarrhea; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Rimonabant; Smoking Cessation; Vomiting

2018

Other Studies

3 other study(ies) available for sr141716 and Diarrhea

ArticleYear
The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
    European journal of pharmacology, 1999, Nov-12, Volume: 384, Issue:1

    Topics: Analgesics; Animals; Antidiarrheals; Benzoxazines; Castor Oil; Cyclohexanols; Defecation; Diarrhea; Dose-Response Relationship, Drug; Gastrointestinal Motility; Gastrointestinal Transit; Loperamide; Male; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant

1999
Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil.
    British journal of pharmacology, 2000, Volume: 129, Issue:8

    Topics: Animals; Antidiarrheals; Benzoxazines; Camphanes; Cannabinoids; Croton Oil; Diarrhea; Gastrointestinal Transit; Male; Mice; Mice, Inbred ICR; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant

2000
Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 298, Issue:3

    Topics: Animals; Behavior, Animal; Cannabinoids; Diarrhea; Dronabinol; Drug Implants; Hallucinogens; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred ICR; Mice, Knockout; Morphine; Morphine Dependence; Narcotics; Opioid Peptides; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid, mu; Rimonabant; Substance Withdrawal Syndrome

2001